Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyelonephritis-associated pili (Pap), commonly referred to as P fimbriae or P pili, are hair-like, multi-protein appendages found on the surface of uropathogenic Escherichia coli (UPEC). These structures are assembled via the highly conserved chaperone-usher pathway, consisting of a rigid rod composed of PapA subunits and a flexible tip fibrillum containing the PapG adhesin. P fimbriae play a critical role in the pathogenesis of upper urinary tract infections, specifically pyelonephritis, by mediating the adherence of UPEC to Gal(alpha1-4)Gal-specific glycosphingolipid receptors (globoseries glycolipids) on human kidney epithelial cells. This attachment prevents the bacteria from being washed away by urine flow and triggers host inflammatory responses. Because of their essential role in colonization and virulence, P fimbriae are attractive therapeutic targets. Small-molecule inhibitors known as pilicides (such as the ring-fused 2-pyridone derivatives like ec240) have been developed to target the periplasmic chaperone PapD, thereby disrupting pilus biogenesis and preventing bacterial adhesion without directly killing the bacteria, which minimizes the selective pressure for antibiotic resistance.
Inhibition of the chaperone-usher pathway by binding to the periplasmic chaperone (e.g., PapD), thereby preventing chaperone-subunit-usher interactions and disrupting pilus biogenesis, which ultimately blocks bacterial adhesion to host tissues.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyelonephritis-associated pili (Pap).